SCHEMBL23239144

SCHEMBL23239144

c1ccc(N(c2cccc(-c3cccc(-c4cccc5ccccc45)c3)c2)c2cccc3c2oc2ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.41
▸ GGPS1 O95749 1/20 0.36
▸ MCL1 Q07820 1/20 0.36
▸ ACMSD Q8TDX5 1/20 0.36
▸ PTGES2 Q9H7Z7 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ MAPT P10636 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ CYP1A1 P04798 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP1B1 Q16678 1/20 0.34
▸ TP53 P04637 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ RELA Q04206 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23238109 0.98 ALOX5 (0.41) ALOX5GGPS1MCL1ACMSDPTGES2
SCHEMBL23224782 0.98 ALOX5 (0.43) ALOX5GGPS1MCL1ACMSDPTGES2
SCHEMBL23239568 0.97 ALOX5 (0.42) ALOX5GGPS1MCL1ACMSDPTGES2
SCHEMBL25824599 0.97 ALOX5 (0.42) ALOX5GGPS1MCL1ACMSDPTGES2
SCHEMBL23224986 0.97 ALOX5 (0.42) ALOX5GGPS1MCL1ACMSDPTGES2
SCHEMBL23238739 0.97 ALOX5 (0.42) ALOX5GGPS1MCL1ACMSDPTGES2
SCHEMBL23239572 0.97 ALOX5 (0.42) ALOX5GGPS1MCL1ACMSDPTGES2
SCHEMBL23224787 0.96 ALOX5 (0.42) ALOX5GGPS1MCL1ACMSDPTGES2
SCHEMBL23238791 0.96 ALOX5 (0.41) ALOX5GGPS1MCL1ACMSDPTGES2
SCHEMBL23239659 0.95 ALOX5 (0.40) ALOX5GGPS1MCL1ACMSDPTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227397-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-07-20 — — US disclosed
US-20230227397-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-07-20 — — US disclosed
WO-2021070964-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2021-04-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227397-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, PIEZO1, ELAVL1 ALOX5 1352/4885GGPS1 1940/4885MCL1 2421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback